Literature DB >> 7704500

Pretreatment minimal staging for non-small cell lung cancer: an updated consensus report.

P Goldstraw1, P Rocmans, D Ball, N Barthelemy, J Bonner, M Carette, N Choi, B Emami, D Grunenwald, M Hazuka.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7704500     DOI： 10.1016/0169-5002(94)91856-2

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  4 in total

1.  Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals.

Authors:  G J M Herder; P Verboom; E F Smit; P C M van Velthoven; J H A M van den Bergh; C D Colder; I van Mansom; J C van Mourik; P E Postmus; G J J Teule; O S Hoekstra
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

Review 2.  Lung Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Paula Manchon; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2009-12       Impact factor: 3.405

3.  Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer.

Authors:  H Osada; K Kojima; H Tsukada; Y Nakajima; K Imamura; J Matsumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-01

Review 4.  Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer.

Authors:  Henk Kramer; Harry J M Groen
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.